SEC and Ripple lock horns amid draft remedy briefs

The legal battle between the U.S. Securities and Exchange Commission (SEC) and Ripple Labs, the company behind the cryptocurrency XRP, has intensified as both parties proceed with drafting remedy-related briefs. This ongoing dispute stems from the SEC’s allegations that Ripple’s XRP token sales constituted unregistered securities offerings, violating federal securities laws. Recent... source: https://www.cryptopolitan.com/sec-and-ripple-draft-remedy-briefs/